Eligibility Obesity NCT02117700

  1. StudyEvent: Eligibility
    1. Eligibility Obesity NCT02117700
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
age 7 years and older
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
nash confirmed in a previous biopsy
Descripción

Nonalcoholic Steatohepatitis | Biopsy Previous

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3241937
UMLS CUI [2,1]
C0005558
UMLS CUI [2,2]
C0205156
hbaic <6.4%
Descripción

Glycosylated hemoglobin A

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0019018
alt > 60 u/l or 1.5 times the upper limit of normal
Descripción

Alanine aminotransferase measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201836
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
chronic liver disease including alpha-1-antitrypsin deficiency, wilson's disease, autoimmune and viral hepatitis
Descripción

Chronic liver disease | alpha 1-Antitrypsin Deficiency | Hepatolenticular Degeneration | Hepatitis, Autoimmune | Viral hepatitis

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0341439
UMLS CUI [2]
C0221757
UMLS CUI [3]
C0019202
UMLS CUI [4]
C0241910
UMLS CUI [5]
C0042721
medications such as adrenergic β-blockers, steroids and other drugs known to interfere with the measurement of liver enzymes and risk factors for cardiovascular disease
Descripción

Pharmaceutical Preparations Interferes with Measurement of liver enzyme | Pharmaceutical Preparations Risk factors Cardiovascular Diseases | Adrenergic beta-Antagonists | Steroids

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0521102
UMLS CUI [1,3]
C0428321
UMLS CUI [2,1]
C0013227
UMLS CUI [2,2]
C0035648
UMLS CUI [2,3]
C0007222
UMLS CUI [3]
C0001645
UMLS CUI [4]
C0038317
heart disease, chronic renal disease, adrenal, hepatic or thyroid dysfunction; active malignancy; and anemia
Descripción

Heart Diseases | Chronic Kidney Diseases | Dysfunction adrenal | Liver Dysfunction | Thyroid dysfunction | Malignant Neoplasms | Anemia

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0018799
UMLS CUI [2]
C1561643
UMLS CUI [3]
C0549609
UMLS CUI [4]
C0086565
UMLS CUI [5]
C0348024
UMLS CUI [6]
C0006826
UMLS CUI [7]
C0002871
history of prior treatment with nac
Descripción

Prior Therapy Acetylcysteine

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C0001047
evidence of hypersensitivity/allergy to nac
Descripción

Hypersensitivity Acetylcysteine

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0001047
alcoholism or drug abuse and smoking
Descripción

Substance Use Disorders | Smoking

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0038586
UMLS CUI [2]
C0037369
inter-current illness over 7 days before the study & surgery in the past 3 mo.
Descripción

Intercurrent disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0277557

Similar models

Eligibility Obesity NCT02117700

  1. StudyEvent: Eligibility
    1. Eligibility Obesity NCT02117700
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
age 7 years and older
boolean
C0001779 (UMLS CUI [1])
Nonalcoholic Steatohepatitis | Biopsy Previous
Item
nash confirmed in a previous biopsy
boolean
C3241937 (UMLS CUI [1])
C0005558 (UMLS CUI [2,1])
C0205156 (UMLS CUI [2,2])
Glycosylated hemoglobin A
Item
hbaic <6.4%
boolean
C0019018 (UMLS CUI [1])
Alanine aminotransferase measurement
Item
alt > 60 u/l or 1.5 times the upper limit of normal
boolean
C0201836 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Chronic liver disease | alpha 1-Antitrypsin Deficiency | Hepatolenticular Degeneration | Hepatitis, Autoimmune | Viral hepatitis
Item
chronic liver disease including alpha-1-antitrypsin deficiency, wilson's disease, autoimmune and viral hepatitis
boolean
C0341439 (UMLS CUI [1])
C0221757 (UMLS CUI [2])
C0019202 (UMLS CUI [3])
C0241910 (UMLS CUI [4])
C0042721 (UMLS CUI [5])
Pharmaceutical Preparations Interferes with Measurement of liver enzyme | Pharmaceutical Preparations Risk factors Cardiovascular Diseases | Adrenergic beta-Antagonists | Steroids
Item
medications such as adrenergic β-blockers, steroids and other drugs known to interfere with the measurement of liver enzymes and risk factors for cardiovascular disease
boolean
C0013227 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0428321 (UMLS CUI [1,3])
C0013227 (UMLS CUI [2,1])
C0035648 (UMLS CUI [2,2])
C0007222 (UMLS CUI [2,3])
C0001645 (UMLS CUI [3])
C0038317 (UMLS CUI [4])
Heart Diseases | Chronic Kidney Diseases | Dysfunction adrenal | Liver Dysfunction | Thyroid dysfunction | Malignant Neoplasms | Anemia
Item
heart disease, chronic renal disease, adrenal, hepatic or thyroid dysfunction; active malignancy; and anemia
boolean
C0018799 (UMLS CUI [1])
C1561643 (UMLS CUI [2])
C0549609 (UMLS CUI [3])
C0086565 (UMLS CUI [4])
C0348024 (UMLS CUI [5])
C0006826 (UMLS CUI [6])
C0002871 (UMLS CUI [7])
Prior Therapy Acetylcysteine
Item
history of prior treatment with nac
boolean
C1514463 (UMLS CUI [1,1])
C0001047 (UMLS CUI [1,2])
Hypersensitivity Acetylcysteine
Item
evidence of hypersensitivity/allergy to nac
boolean
C0020517 (UMLS CUI [1,1])
C0001047 (UMLS CUI [1,2])
Substance Use Disorders | Smoking
Item
alcoholism or drug abuse and smoking
boolean
C0038586 (UMLS CUI [1])
C0037369 (UMLS CUI [2])
Intercurrent disease
Item
inter-current illness over 7 days before the study & surgery in the past 3 mo.
boolean
C0277557 (UMLS CUI [1])